Shareholder information


Upcoming events

Q1 2020 Results

This data might not be the latest available


Annual General Meeting

The meeting place for AstraZeneca’s Annual General Meeting will be Leonardo Royal Hotel London Tower Bridge, 45 Prescot St, London, E1 8GP and the AGM will commence at 2.30 pm BST on 29 April 2020. Full details are included in the Notice of AGM.

AstraZeneca continues to monitor the situation in relation to COVID-19 and will notify shareholders here on the AstraZeneca website as soon as practicably possible if there are any changes to the AGM arrangements.

Your vote is very important to AstraZeneca. We understand that shareholders may not want or be able to travel to the AGM. Shareholders are reminded of their right to appoint the Chairman of the AGM as their proxy to vote on their behalf at the AGM.

 



 

Shareholder forms

You can download a selection of our registrar instruction forms here. If you can't find the form you require please go to the Equiniti Shareview website.

 


Completed forms should be returned to:

Equiniti Limited
Aspect House
Spencer Road
Lancing
West Sussex
BN99 6DA


For more information, shareholder services and changes to personal details, visit the Equiniti website.



Investor enquiries

Main Contacts

Thomas Kudsk Larsen

Henry Wheeler

Oncology

Josie Afolabi

BioPharmaceuticals (Respiratory)

Craig Marks

Finance, fixed income

Christer Gruvris

BioPharmaceuticals (CV, Metabolism)

Tom Waldron

Other medicines

Jennifer Kretzmann

Corporate access, retail investors

Nick Stone

BioPharmaceuticals (Renal), ESG

US general enquiries